BCR and acquired polycythemia vera: Myeloproliferative neoplasms, namely the BCR::ABL1-negative subtypes such as polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are identified as clonal hematopoietic stem cell conditions marked by the aberrant proliferation of myeloid lineages.